International Journal of Cutaneous Disorders & Medicine ISSN: 2691-5839
Case Report
Psoriasis Vulgaris (PV) Exacerbation in Acute Myeloid Leukemia (AML) Patient Treated with Cytarabine/Daunorubicin (C/D)
Published: 2024-11-20

Abstract

Adverse reactions associated with chemotherapeutic agents to treat acute leukemia such as cytarabine and daunorubicin (C/D) have been reported regularly, however, psoriasis vulgaris is a rare adverse event. We report a 46-year-old Indonesian man presented with multiple erythema scaly plaques on his trunk for one month. He was diagnosed with acute myeloid leukemia (AML) 4 months ago, and received remission-induction chemotherapy for AML with a high-dose combination of C/D.

Keywords

Acute Myeloid Leukemia; Cytarabine; Daunorubicin; Psoriasis Vulgaris